Amneal Delivers On Biosimilars Ambitions With Neupogen Rival
Company Also Reveals Plans For 20-30 Generics Launches In 2022
• By Akriti Seth
Amneal plans to grow on the back of new generics and biosimilar launches and pending approvals • Source: Alamy 
